Balentine LLC’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,770
Closed -$253K 525
2024
Q1
$253K Buy
+16,770
New +$304K 0.01% 441
2022
Q2
Sell
-2,906
Closed -$210K 699
2022
Q1
$210K Buy
+2,906
New +$209K 0.01% 540
2020
Q3
Sell
-89
Closed -$17K 766
2020
Q2
$17K Buy
+89
New +$15.6K ﹤0.01% 429

Other funds holding TDOC

Balentine LLC's TDOC Position: Q2 2024 in Review

Balentine LLC sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 16,770 shares — an estimated $253K sold.

Balentine LLC first reported a position in TDOC in Q2 2020 and held it in 3 quarters. The position peaked at $253K in Q1 2024. 405 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Balentine LLC reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 16,770 Teladoc Health shares in Q2 2024, an estimated $253K.
  • Balentine LLC first reported a position in Teladoc Health in Q2 2020 and held it in 3 quarters.
  • Balentine LLC's Teladoc Health position peaked at $253K in Q1 2024.
  • 405 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.